| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.40B | $16.91B | $17.23B |
| YoY Revenue Growth % | +2.9% | -1.8% | — |
| Gross Profit | $8.23B | $7.38B | — |
| Gross Margin % | 47.3% | 43.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.29B | $1.07B | $867.3M |
| Operating Margin % | 7.4% | 6.3% | 5.0% |
| Net Income (GAAP) | $1.09B | $907.0M | $735.0M |
| EBITDA (Normalized) | $1.92B | $1.68B | $1.49B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.41B | $2.15B | $1.77B |
| Capital Expenditures (CapEx) | $783.0M | $760.9M | $775.2M |
| Free Cash Flow (FCF) | $2.62B | $1.38B | $993.8M |
| FCF Margin % | 15.1% | 8.2% | 5.8% |
| Return on Invested Capital (ROIC %) | 3.4% | 2.8% | 5.5% |
| Cash & Short-Term Equivalents | $4.52B | $3.11B | — |
| Total Debt (Short + Long Term) | $10.03B | $9.55B | $4.84B |
| Total Stockholders' Equity | $24.14B | $23.79B | $9.92B |